Ervin Horváth

696 total citations
19 papers, 600 citations indexed

About

Ervin Horváth is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, Ervin Horváth has authored 19 papers receiving a total of 600 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cellular and Molecular Neuroscience, 9 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in Ervin Horváth's work include Neuroscience and Neuropharmacology Research (12 papers), Ion channel regulation and function (5 papers) and Receptor Mechanisms and Signaling (4 papers). Ervin Horváth is often cited by papers focused on Neuroscience and Neuropharmacology Research (12 papers), Ion channel regulation and function (5 papers) and Receptor Mechanisms and Signaling (4 papers). Ervin Horváth collaborates with scholars based in Germany, Bulgaria and France. Ervin Horváth's co-authors include Frank Mauler, Jean De Vry, Klaus Urbahns, Thomas Fahrig, Joachim Mittendorf, Volker Hinz, F. Josef van der Staay, R. Jork, Johannes-Peter Stasch and J. Traber and has published in prestigious journals such as Brain Research, Journal of Pharmacology and Experimental Therapeutics and Journal of Cerebral Blood Flow & Metabolism.

In The Last Decade

Ervin Horváth

19 papers receiving 570 citations

Peers

Ervin Horváth
Deborah R. McCarty United States
Jean Rataud France
Franck Désarnaud France
Kazuo Koshiya Japan
E. Horváth Germany
Gisela Kindel United States
Jean-Christophe Delumeau France
C.Z. Zhu United States
Pierrick Gandolfo France
Hussam Jourdi United States
Deborah R. McCarty United States
Ervin Horváth
Citations per year, relative to Ervin Horváth Ervin Horváth (= 1×) peers Deborah R. McCarty

Countries citing papers authored by Ervin Horváth

Since Specialization
Citations

This map shows the geographic impact of Ervin Horváth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ervin Horváth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ervin Horváth more than expected).

Fields of papers citing papers by Ervin Horváth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ervin Horváth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ervin Horváth. The network helps show where Ervin Horváth may publish in the future.

Co-authorship network of co-authors of Ervin Horváth

This figure shows the co-authorship network connecting the top 25 collaborators of Ervin Horváth. A scholar is included among the top collaborators of Ervin Horváth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ervin Horváth. Ervin Horváth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Mauler, Frank & Ervin Horváth. (2005). Neuroprotective Efficacy of Repinotan HCl, a 5-HT1A Receptor Agonist, in Animal Models of Stroke and Traumatic Brain Injury. Journal of Cerebral Blood Flow & Metabolism. 25(4). 451–459. 36 indexed citations
2.
3.
Urbahns, Klaus, Siegfried Goldmann, Jochen Krüger, et al.. (2004). IKCa-channel blockers. Part 2: Discovery of cyclohexadienes. Bioorganic & Medicinal Chemistry Letters. 15(2). 401–404. 20 indexed citations
4.
Mauler, Frank, Ervin Horváth, Jean De Vry, et al.. (2003). BAY 38–7271: A Novel Highly Selective and Highly Potent Cannabinoid Receptor Agonist for the Treatment of Traumatic Brain Injury. CNS Drug Reviews. 9(4). 343–358. 27 indexed citations
5.
Urbahns, Klaus, Ervin Horváth, Johannes-Peter Stasch, & Frank Mauler. (2003). 4-Phenyl-4H-pyrans as IKCa channel blockers. Bioorganic & Medicinal Chemistry Letters. 13(16). 2637–2639. 60 indexed citations
6.
Mauler, Frank, et al.. (2003). Neuroprotective and brain edema-reducing efficacy of the novel cannabinoid receptor agonist BAY 38-7271. Brain Research. 989(1). 99–111. 46 indexed citations
7.
Urbahns, Klaus, Ervin Horváth, Johannes‐Peter Stasch, & Frank Mauler. (2003). 4‐Phenyl‐4H‐pyrans as IKCa Channel Blockers.. ChemInform. 34(50). 2 indexed citations
8.
Mauler, Frank, Joachim Mittendorf, Ervin Horváth, & Jean De Vry. (2002). Characterization of the Diarylether Sulfonylester (−)-(R)-3-(2-Hydroxymethylindanyl-4-oxy)phenyl-4,4,4-trifluoro-1-sulfonate (BAY 38-7271) as a Potent Cannabinoid Receptor Agonist with Neuroprotective Properties. Journal of Pharmacology and Experimental Therapeutics. 302(1). 359–368. 83 indexed citations
9.
Biervert, Christian, Ervin Horváth, & Thomas Fahrig. (2001). Semiquantitative expression analysis of ephrine-receptor tyrosine kinase mRNA's in a rat model of traumatic brain injury. Neuroscience Letters. 315(1-2). 25–28. 22 indexed citations
10.
Mauler, Frank, Thomas Fahrig, Ervin Horváth, & R. Jork. (2001). Inhibition of evoked glutamate release by the neuroprotective 5-HT1A receptor agonist BAY x 3702 in vitro and in vivo. Brain Research. 888(1). 150–157. 72 indexed citations
11.
Vry, Jean De, et al.. (2001). Neuroprotective and behavioral effects of the selective metabotropic glutamate mGlu1 receptor antagonist BAY 36-7620. European Journal of Pharmacology. 428(2). 203–214. 53 indexed citations
12.
Beck, Thomas, Michael Weber, Ervin Horváth, & Andreas Wree. (1996). Functional Cerebral Activity during Regeneration from Entorhinal Lesions in the Rat. Journal of Cerebral Blood Flow & Metabolism. 16(2). 342–352. 7 indexed citations
13.
14.
15.
Spencer, David, Ervin Horváth, J. Traber, & Lucio A.A. Van Rooijen. (1988). GTP effects in rat brain slices support the non-interconvertability of M1 and M2 muscarinic acetylcholine receptors. Life Sciences. 42(9). 993–997. 4 indexed citations
16.
Wree, Andreas, Karl Zilles, Axel Schleicher, Ervin Horváth, & J. Traber. (1987). Effect of the 5-HT1A receptor agonist ipsapirone on the local cerebral glucose utilization of the rat hippocampus. Brain Research. 436(2). 283–290. 32 indexed citations
17.
Horváth, Ervin, Lucio A.A. Van Rooijen, J. Traber, & David Spencer. (1986). Effects of N-ethylmaleimide on muscarinic acetylcholine receptor subtype autoradiography and inositide response in rat brain. Life Sciences. 39(13). 1129–1135. 12 indexed citations
18.
Rooijen, Lucio A.A. Van, et al.. (1986). Chapter 6 Pharmacological aspects of the inositide response in the central nervous system: the muscarinic acetylcholine receptor. Progress in brain research. 69. 65–74. 4 indexed citations
19.
Rooijen, Lucio A.A. Van, et al.. (1986). The M1-muscarinic acetylcholine receptor subtype is linked to the inositide cycle in rat brain synaptosomes. Biochemical Society Transactions. 14(6). 1261–1262. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Deborah R. McCarty Breakdown of academic impact, for papers by Jean Rataud Breakdown of academic impact, for papers by Franck Désarnaud Breakdown of academic impact, for papers by Kazuo Koshiya Breakdown of academic impact, for papers by E. Horváth Breakdown of academic impact, for papers by Gisela Kindel Breakdown of academic impact, for papers by Jean-Christophe Delumeau Breakdown of academic impact, for papers by C.Z. Zhu Breakdown of academic impact, for papers by Pierrick Gandolfo Breakdown of academic impact, for papers by Hussam Jourdi
Rankless by CCL
2026